Literature DB >> 2933339

Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.

S Laal, L K Bhutani, I Nath.   

Abstract

Fifteen lepromatous leprosy (LL) patients undergoing erythema nodosum leprosum (ENL) reactions were compared with 13 stable, uncomplicated, anergic individuals of the same leprosy background. ENL patients showed significant antigen-induced leukocyte migration inhibition (migration index = 0.058 +/- 0.01), paralleling the values obtained with a responder tuberculoid leprosy population (migration index = 0.04 +/- 0.004). Both phytohemagglutinin-induced general T-cell proliferation and, more significantly, antigen-induced lymphoproliferation were enhanced during the acute phase of the reaction. Suppressor cell activity, monitored by a costimulant assay, showed enhanced antigen-stimulated suppression of mitogen responses. Interestingly, the improvement in in vitro T-cell responses was not reflected in dermal reactivity, since 48-h delayed-type hypersensitivity responses after intradermal injection of soluble Mycobacterium leprae antigens continued to be poor. After subsidence of reactional lesions, leukocyte migration inhibition, lymphoproliferation, and suppressor cell activity were reduced to the unresponsive state seen in stable LL patients. Significantly, perturbations of T-cell reactivity are detectable in ENL reactions, indicating the natural but transient emergence of antigen-induced T cells in LL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2933339      PMCID: PMC261163          DOI: 10.1128/iai.50.3.887-892.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  SDS-PAGE analysis of M. leprae protein antigens reacting with antibodies from sera from lepromatous patients and infected armadillos.

Authors:  A K Chakrabarty; M A Maire; P H Lambert
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

2.  The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.

Authors:  I Nath; R Singh
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

3.  Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

Authors:  M Sathish; L K Bhutani; A K Sharma; I Nath
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

4.  T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy.

Authors:  A Haregewoin; T Godal; A S Mustafa; A Belehu; T Yemaneberhan
Journal:  Nature       Date:  1983-05-26       Impact factor: 49.962

5.  Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population.

Authors:  G L Stoner; R N Mshana; J Touw; A Belehu
Journal:  Scand J Immunol       Date:  1982-01       Impact factor: 3.487

6.  Mechanism of immunosuppression in leprosy: presence of suppressor factor(s) from macrophages of lepromatous patients.

Authors:  P R Salgame; P R Mahadevan; N H Antia
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy.

Authors:  W E Bullock; S Watson; K E Nelson; V Schauf; S Makonkawkeyoon; R R Jacobson
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  Imbalances in T cell subpopulations in lepromatous leprosy.

Authors:  D Wallach; F Cottenot; M A Bach
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-09

9.  Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies.

Authors:  R N Mshana; A Haregewoin; M Harboe; A Belehu
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-09

10.  Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.

Authors:  I Nath; J J Van Rood; N K Mehra; M C Vaidya
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

View more
  16 in total

1.  Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy.

Authors:  Mehervani Chaduvula; A Murtaza; Namita Misra; N P Shankar Narayan; V Ramesh; H K Prasad; Rajni Rani; R K Chinnadurai; Indira Nath
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy.

Authors:  T H Rea; J Y Shen; R L Modlin
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions.

Authors:  P Sreenivasan; R S Misra; D Wilfred; I Nath
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

4.  Accessory cell heterogeneity in lepromatous leprosy; dendritic cells and not monocytes support T cell responses.

Authors:  A Mittal; R S Mishra; I Nath
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

5.  The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.

Authors:  J de Souza Sales; F A Lara; T P Amadeu; T de Oliveira Fulco; J A da Costa Nery; E P Sampaio; R O Pinheiro; E N Sarno
Journal:  Clin Exp Immunol       Date:  2011-05-18       Impact factor: 4.330

6.  Sera of leprosy patients with type 2 reactions recognize selective sequences in Mycobacterium leprae recombinant LSR protein.

Authors:  S Singh; N P Narayanan; P J Jenner; G Ramu; M J Colston; H K Prasad; I Nath
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

7.  Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy.

Authors:  Chaman Saini; H K Prasad; Rajni Rani; A Murtaza; Namita Misra; N P Shanker Narayan; Indira Nath
Journal:  Clin Vaccine Immunol       Date:  2013-02-27

8.  Complex Type 2 Reactions in Three Patients with Hansen's Disease from a Southern United States Clinic.

Authors:  Kristoffer E Leon; Jorge L Salinas; Robert W McDonald; Anandi N Sheth; Jessica K Fairley
Journal:  Am J Trop Med Hyg       Date:  2015-08-24       Impact factor: 2.345

9.  Critical residues of the Mycobacterium leprae LSR recombinant protein discriminate clinical activity in erythema nodosum leprosum reactions.

Authors:  S Singh; P J Jenner; N P Narayan; G Ramu; M J Colston; H K Prasad; I Nath
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.

Authors:  E P Sampaio; A L Moreira; E N Sarno; A M Malta; G Kaplan
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.